TREA

79189100 - FLUOROPASSIV

Follow

Information

  • Trademark
  • 79189100
  • Serial Number
    79189100
  • Registration Number
    5135131
  • Filing Date
    March 31, 2016
    8 years ago
  • Registration Date
    February 07, 2017
    8 years ago
  • Transaction Date
    April 30, 2024
    10 months ago
  • Status Date
    August 18, 2023
    a year ago
  • Published for Opposition Date
    November 22, 2016
    8 years ago
  • Location Date
    February 07, 2017
    8 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VAGHANI, MAYUR C
  • Attorney Docket Number
    400352-20205
    Attorney Name
    JEFFREY H. GREGER
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
FLUOROPASSIV
Case File Statements
  • TR0010: The wording "FLUOROPASSIV" has no meaning.
  • GS0101: Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stents, vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, and vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devices, namely, aneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, surgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; thin wall carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Case File Event Statements
  • 7/14/2016 - 8 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/15/2016 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/15/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/8/2016 - 8 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/22/2016 - 8 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/19/2016 - 8 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/19/2016 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/20/2016 - 8 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/20/2016 - 8 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/20/2016 - 8 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/5/2016 - 8 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/8/2016 - 8 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/17/2016 - 8 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 9/22/2016 - 8 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/13/2016 - 8 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/2/2016 - 8 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/22/2016 - 8 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/22/2016 - 8 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/7/2017 - 8 years ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/7/2017 - 7 years ago
    21 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/3/2017 - 7 years ago
    23 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/24/2017 - 7 years ago
    24 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/7/2022 - 3 years ago
    25 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 4/18/2024 - 10 months ago
    27 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 4/30/2024 - 10 months ago
    29 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 4/30/2024 - 10 months ago
    28 - INVALIDATION PROCESSED Type: INPC
  • 5/21/2024 - 9 months ago
    30 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 10/17/2016 - 8 years ago
    16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/3/2017 - 7 years ago
    22 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 8/18/2023 - a year ago
    26 - CANCELLED SECTION 71 Type: C71T